Rating History for Vor Biopharma, Inc. (VOR) by Wells Fargo
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2026 | N/A | New Coverage | Overweight (N/A) |
30.00 (N/A) |
13.00 (14.49) |
11.46% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2026 | N/A | New Coverage | Overweight (N/A) |
30.00 (N/A) |
13.00 (14.49) |
11.46% | Details |